Mounjaro's action in the body — what it does and why it matters

The decision most people are really weighing up

If you are researching Mounjaro's action, you are probably trying to answer a practical question: does this medicine work differently enough from other options to matter? The honest answer is yes, and understanding why helps you have a more useful conversation with a prescriber.

Most GLP-1 medicines, including semaglutide (Wegovy), activate a single receptor. Tirzepatide activates two: the GLP-1 receptor and the GIP (glucose-dependent insulinotropic polypeptide) receptor. GIP is a gut hormone released after eating; in normal physiology it signals fullness and plays a role in fat storage and energy balance. By engaging both receptors, tirzepatide produces a pattern of signals that clinical trial data suggest is additive, the combined effect on appetite appears greater than either alone. You can read more about the underlying pharmacology on our tirzepatide action page.

That said, a more potent mechanism does not automatically mean the right choice for every person. Tolerability, medical history, other medicines you take, and what your life actually looks like week to week all factor in. That is precisely what a clinical assessment is for.

What happens after each weekly injection

After you inject, tirzepatide begins to bind to GIP and GLP-1 receptors in the gut, pancreas, and brain. The result is a cluster of effects that build over the following days: appetite falls, food feels more satisfying in smaller amounts, and gastric emptying slows so the physical sensation of fullness lasts longer. Blood-sugar responses to meals also smooth out, relevant both for weight management and for its licensed type 2 diabetes indication.

Because the receptor activation is gradual and sustained over seven days, a single injection covers the whole week. The starting dose is set deliberately low (2.5 mg) not because it is therapeutic at that level, but because it gives your system time to adjust before the dose steps up. The onset of tirzepatide's effects is not instant; many people notice appetite changes within the first week or two, though meaningful weight changes tend to emerge over months.

The SURMOUNT-1 trial, published in the New England Journal of Medicine, found average body-weight reductions of around 20–21% at the 15 mg dose over 72 weeks. Those figures come from a controlled trial setting; your own results will depend on a range of factors your prescriber can discuss with you. The tirzepatide overview covers the evidence in full.

How the mechanism shapes the side-effect profile

Understanding the action also makes the side effects easier to anticipate. Because tirzepatide slows gastric emptying and activates gut receptors, gastrointestinal effects are the most commonly reported: nausea, loose stools, constipation, indigestion, and burping are all on the list. They are most noticeable when a dose step happens and tend to settle within a week or two for most people, once the body adjusts.

The low starting dose exists partly for this reason. A question our prescribers hear fairly often is whether the side effects mean something is going wrong, in most cases they are a predictable consequence of the mechanism, not a sign of a problem. That said, severe or persistent stomach pain that radiates to the back should always be assessed urgently, and the NHS tirzepatide medicines page lists the full side-effect profile alongside when to seek help.

For a detailed read of the clinical data behind the mechanism, the Mounjaro mechanism of action page goes deeper on the pharmacology. And if you want to understand how long each dose's effects last across the week, the duration of action page covers that specifically.

Where this leaves your next step

Knowing how Mounjaro works is a reasonable starting point, it is the kind of information that makes a consultation more productive. What the mechanism cannot tell you is whether tirzepatide is the right medicine for your particular circumstances, or whether Wegovy or another option is a better fit. That judgment sits with a prescriber who has seen your full picture.

If you are comparing costs between providers before booking a consultation, the Mounjaro price comparison page sets out what private treatment typically costs and what different price points actually include. It is worth reading before assuming the lowest number represents the best deal.

At nume, every consultation is read by a real prescriber (not a scoring algorithm) and if treatment is clinically appropriate, your prescription is issued the same day. There is no subscription; each repeat order goes through a fresh clinical review. If you would like to talk through whether Mounjaro is suitable for you, speak to our prescribers and start your free consultation. The Mounjaro overview is also a useful read if you want the full picture before you do. A quick note from our clinical team: the Patient Information Leaflet supplied with your pen remains the authoritative source on dosing, storage, and what to do if you miss an injection, our prescribers can point you to it, but it is the document that legally governs your use of the medicine. The full prescribing detail is also held in the tirzepatide PIL.